Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Clinical trial NCT05975983 · RECRUITING
Trial details
- NCT number
- NCT05975983
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2026-02-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.